Metal Complex Formation and Anticancer Activity of Cu(I) and Cu(II) Complexes with Metformin
Lachowicz, Joanna Izabela
KAUST DepartmentBiological and Environmental Science and Engineering (BESE) Division
Computational Bioscience Research Center (CBRC)
Environmental Science and Engineering Program
Laboratory for Nanomedicine, Division of Biological and Environmental Science and Engineering, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.
Permanent link to this recordhttp://hdl.handle.net/10754/670468
MetadataShow full item record
AbstractMetformin has been used for decades in millions of type 2 diabetes mellitus patients. In this time, correlations between metformin use and the occurrence of other disorders have been noted, as well as unpredictable metformin side effects. Diabetes is a significant cancer risk factor, but unexpectedly, metformin-treated diabetic patients have lower cancer incidence. Here, we show that metformin forms stable complexes with copper (II) ions. Both copper(I)/metformin and copper(II)/metformin complexes form adducts with glutathione, the main intracellular antioxidative peptide, found at high levels in cancer cells. Metformin reduces cell number and viability in SW1222 and K562 cells, as well as in K562-200 multidrug-resistant cells. Notably, the antiproliferative effect of metformin is enhanced in the presence of copper ions.
CitationAbdelrahman, S., Alghrably, M., Campagna, M., Hauser, C. A. E., Jaremko, M., & Lachowicz, J. I. (2021). Metal Complex Formation and Anticancer Activity of Cu(I) and Cu(II) Complexes with Metformin. Molecules, 26(16), 4730. doi:10.3390/molecules26164730
SponsorsWe would like to thank Farid Ahmad from the center of excellence in genomic medicine research (CEGMR) for providing both the K562 and K562/Adr200 cell lines.
Except where otherwise noted, this item's license is described as This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.